Browsing by Author Timpson, Paul

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 17 of 17
Issue DateTitleAuthor(s)Citation
2017Annexin A6 A multifunctional scaffold in cell motilityBeevi, Syed; Grewal, Thomas; Hoque, Monira; Wahba, Mohamed; Conway, James; Enrich, Carlos; Rentero, Carles; Reverter, Meritxell; Timpson, Paul; Pharmacy; Pharmacy; Pharmacy; PharmacyAnnexin A6 A multifunctional scaffold in cell motility, Cell Adhesion and Migration, vol.11, 3, 2017,pp 288-304
2009Annexin A6 inhibits Ras signalling in breast cancer cellsEvans, Rachel; Grewal, (Ranjit) Thomas; Hayes, Tony; Hegemann, Anika; Leschner, Jasmin; Cubells, Laia; Daly, Roger; Enrich, Carlos; Pol, Albert; Rentero, Carles; Reverter, M; Tebar, Francesc; Timpson, Paul; Vila de Muga, Sandra; Pharmacy; Pharmacy; Pharmacy; Pharmacy; PharmacyAnnexin A6 inhibits Ras signalling in breast cancer cells, Oncogene: including Oncogene Reviews, vol.28, N/A,pp 363-377
2015The cross-talk of LDL-cholesterol with cell motility: Insights from the Niemann Pick Type C1 mutation and altered integrin traffickingGrewal, Thomas; Hoque, Monira; Conway, James; Enrich, Carlos; Murray, Rachael; Rentero, Carles; Timpson, Paul; Pharmacy; PharmacyThe cross-talk of LDL-cholesterol with cell motility: Insights from the Niemann Pick Type C1 mutation and altered integrin trafficking, Cell adhesion & migration, vol.9, 5, 2015,pp 384-391
2016The (delta)133p53 isoform and its mouse analogue (delta)122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2Braithwaite, Antony; Campbell, Hamish; Rubio, Carina; Baird, Margaret A.; Berridge, M. V.; Fleming, Nicholas I; Roth, I.; Timpson, Paul; Vennin, Claire; Wiles, Anna K; Williams, G; Wilson, Michelle; Woolley, A; Children's Hospital Westmead: Childrens Medical Research Ins; Children's Hospital Westmead: Childrens Medical Research Ins; Children's Hospital Westmead: Childrens Medical Research InsThe (delta)133p53 isoform and its mouse analogue (delta)122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2, Oncogene, vol.35, 38, 2016,pp 4981-4989
2018delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signallingBraithwaite, Antony; Campbell, Hamish; Reddel, Roger; Arsic, Nikola; Baird, Margaret A.; Black, Michael A.; Fleming, Nicholas I.; McCall, John; McNoe, Les; Mehta, Sunali; Munro, Fran M.; Pajic, Marina; Parkin, Ashleigh; Print, Cristin; Roth, I.; Roux, Pierre; Slatter, T L; Timpson, Paul; Vennin, Claire; Wiles, Anna K; Williams, G; Childrens Medical Research Ins; Childrens Medical Research Ins; Childrens Medical Research Institute (CMRI)delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling, Nature Communications, vol.9, N/A, 2018,pp 1-13
2018delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signallingBraithwaite, Antony; Campbell, Hamish; Reddel, Roger; Arsic, Nikola; Baird, Margaret A.; Black, Michael A.; Fleming, Nicholas I.; McCall, John; McNoe, Les; Mehta, Sunali; Munro, Fran M.; Pajic, Marina; Parkin, Ashleigh; Print, Cristin; Roth, I.; Roux, Pierre; Slatter, T L; Timpson, Paul; Vennin, Claire; Wiles, Anna K; Williams, G; Childrens Medical Research Ins; Childrens Medical Research Ins; Childrens Medical Research Institute (CMRI)delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling, Nature Communications, vol.9, N/A, 2018,pp 1-13
2018delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signallingBraithwaite, Antony; Campbell, Hamish; Reddel, Roger; Arsic, Nikola; Baird, Margaret A.; Black, Michael A.; Fleming, Nicholas I.; McCall, John; McNoe, Les; Mehta, Sunali; Munro, Fran M.; Pajic, Marina; Parkin, Ashleigh; Print, Cristin; Roth, I.; Roux, Pierre; Slatter, T L; Timpson, Paul; Vennin, Claire; Wiles, Anna K; Williams, G; Childrens Medical Research Ins; Childrens Medical Research Ins; Childrens Medical Research Institute (CMRI)delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling, Nature Communications, vol.9, N/A, 2018,pp 1-13
2018delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signallingBraithwaite, Antony; Campbell, Hamish; Reddel, Roger; Arsic, Nikola; Baird, Margaret A.; Black, Michael A.; Fleming, Nicholas I.; McCall, John; McNoe, Les; Mehta, Sunali; Munro, Fran M.; Pajic, Marina; Parkin, Ashleigh; Print, Cristin; Roth, I.; Roux, Pierre; Slatter, T L; Timpson, Paul; Vennin, Claire; Wiles, Anna K; Williams, G; Childrens Medical Research Ins; Childrens Medical Research Ins; Childrens Medical Research Institute (CMRI)delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling, Nature Communications, vol.9, N/A, 2018,pp 1-13
2018delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signallingBraithwaite, Antony; Campbell, Hamish; Reddel, Roger; Arsic, Nikola; Baird, Margaret A.; Black, Michael A.; Fleming, Nicholas I.; McCall, John; McNoe, Les; Mehta, Sunali; Munro, Fran M.; Pajic, Marina; Parkin, Ashleigh; Print, Cristin; Roth, I.; Roux, Pierre; Slatter, T L; Timpson, Paul; Vennin, Claire; Wiles, Anna K; Williams, G; Childrens Medical Research Ins; Childrens Medical Research Ins; Childrens Medical Research Institute (CMRI)delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling, Nature Communications, vol.9, N/A, 2018,pp 1-13
2018delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signallingBraithwaite, Antony; Campbell, Hamish; Reddel, Roger; Arsic, Nikola; Baird, Margaret A.; Black, Michael A.; Fleming, Nicholas I.; McCall, John; McNoe, Les; Mehta, Sunali; Munro, Fran M.; Pajic, Marina; Parkin, Ashleigh; Print, Cristin; Roth, I.; Roux, Pierre; Slatter, T L; Timpson, Paul; Vennin, Claire; Wiles, Anna K; Williams, G; Childrens Medical Research Ins; Childrens Medical Research Ins; Childrens Medical Research Institute (CMRI)delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling, Nature Communications, vol.9, N/A, 2018,pp 1-13
2018delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signallingBraithwaite, Antony; Campbell, Hamish; Reddel, Roger; Arsic, Nikola; Baird, Margaret A.; Black, Michael A.; Fleming, Nicholas I.; McCall, John; McNoe, Les; Mehta, Sunali; Munro, Fran M.; Pajic, Marina; Parkin, Ashleigh; Print, Cristin; Roth, I.; Roux, Pierre; Slatter, T L; Timpson, Paul; Vennin, Claire; Wiles, Anna K; Williams, G; Childrens Medical Research Ins; Childrens Medical Research Ins; Childrens Medical Research Institute (CMRI)delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling, Nature Communications, vol.9, N/A, 2018,pp 1-13
2018delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signallingBraithwaite, Antony; Campbell, Hamish; Reddel, Roger; Arsic, Nikola; Baird, Margaret A.; Black, Michael A.; Fleming, Nicholas I.; McCall, John; McNoe, Les; Mehta, Sunali; Munro, Fran M.; Pajic, Marina; Parkin, Ashleigh; Print, Cristin; Roth, I.; Roux, Pierre; Slatter, T L; Timpson, Paul; Vennin, Claire; Wiles, Anna K; Williams, G; Childrens Medical Research Ins; Childrens Medical Research Ins; Childrens Medical Research Institute (CMRI)delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling, Nature Communications, vol.9, N/A, 2018,pp 1-13
2018delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signallingBraithwaite, Antony; Campbell, Hamish; Reddel, Roger; Arsic, Nikola; Baird, Margaret A.; Black, Michael A.; Fleming, Nicholas I.; McCall, John; McNoe, Les; Mehta, Sunali; Munro, Fran M.; Pajic, Marina; Parkin, Ashleigh; Print, Cristin; Roth, I.; Roux, Pierre; Slatter, T L; Timpson, Paul; Vennin, Claire; Wiles, Anna K; Williams, G; Childrens Medical Research Ins; Childrens Medical Research Ins; Childrens Medical Research Institute (CMRI)delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling, Nature Communications, vol.9, N/A, 2018,pp 1-13
2015FAK Signaling in Human Cancer as a Target for TherapeuticsHorvath, Lisa; Daly, Roger J.; Lee, Brian; Timpson, Paul; Central Clinical School: MedicineFAK Signaling in Human Cancer as a Target for Therapeutics, Pharmacology & Therapeutics, vol.146, N/A, 2015,pp 132-149
2008Protein kinase Cδ and calmodulin regulate epidermal growth factor receptor recycling from early endosomes through Arp2/3 complex and cortactinGrewal, Thomas; Daly, Roger; de Muga, Sandra Vila; Enrich, Carlos; Llado, Anna; Moreto´, Jemina; Pol, Albert; Tebar, Francesc; Timpson, Paul; PharmacyProtein kinase Cδ and calmodulin regulate epidermal growth factor receptor recycling from early endosomes through Arp2/3 complex and cortactin, Molecular Biology of the Cell, vol.19, 1, 2008,pp 17-29
2015Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunitiesGill, Anthony; Biankin, Andrew; Chin, Venessa; Chou, Angela; Nagrial, Adnan; Pajic, Marina; Timpson, Paul; Northern Clinical School: PathologyRho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities, Expert Reviews in Molecular Medicine, vol.17, N/A, 2015,pp e17-N/A
2015Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacyAu, Amy; et al, Various; Jamieson, Nigel B; Leach, Joshua; McGarry, Lynn; McGhee, Ewan; Miller, Bryan W; Morton, Jennifer; Pinese, Mark; Saturno, Grazia; Shanks, Emma; Timpson, Paul; Northern Clinical School: Kolling InstituteTargeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy, EMBO Molecular Medicine (Online), vol.7, 8, 2015,pp 1063-1076